Ocular Therapeutix OCUL Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $737.06M+88.0% | $392.1M+100% | $195.81M+91.4% | $102.3M-37.7% | ||
| $30.65M-5.4% | $32.39M+23.7% | $26.18M+22.8% | $21.33M+0.9% | ||
| $3.56M+17.2% | $3.04M+31.9% | $2.31M+16.8% | $1.97M+57.9% | ||
| $782.13M+77.4% | $440.99M+89.9% | $232.24M+79.2% | $129.63M-32.2% | ||
| $19.68M+110% | $9.39M-20.0% | $11.74M+19.1% | $9.86M+41.7% | ||
| $808.06M+76.5% | $457.94M+81.7% | $252.06M+68.8% | $149.29M-27.1% | ||
| $4.15M-0.5% | $4.18M-4.9% | $4.39M-14.3% | $5.12M+11.6% | ||
| $50.81M+22.9% | $41.35M+18.5% | $34.9M+11.2% | $31.4M+19.2% | ||
| $71.34M+4.1% | $68.51M+4.1% | $65.79M+160% | $25.26M+1.0% | ||
| $153.75M+7.8% | $142.59M-11.4% | $160.93M+41.3% | $113.91M-2.5% | ||
| $22K+37.5% | $16K+33.3% | $12K+50.0% | $8K0.0% | ||
| -$1.16B-29.8% | -$891.08M-27.7% | -$697.58M-13.1% | -$616.84M-13.0% | ||
| $654.31M+107% | $315.34M+246% | $91.13M+158% | $35.38M-59.8% | ||
| $808.06M+76.5% | $457.94M+81.7% | $252.06M+68.8% | $149.29M-27.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Ocular Therapeutix's total assets?
- Ocular Therapeutix (OCUL) holds $732.5M in total assets, up 80.5% year over year.
- How much debt does Ocular Therapeutix have?
- Ocular Therapeutix carries $79.5M in total debt against $581.6M of shareholders' equity, a debt-to-equity ratio of 0.14.
- How much cash does Ocular Therapeutix have?
- Ocular Therapeutix holds $666.7M in cash and equivalents.
- Can Ocular Therapeutix cover its short-term obligations?
- Its current ratio is 14.81 — current assets exceed current liabilities.
- Where does Ocular Therapeutix's balance sheet data come from?
- Every line is extracted from Ocular Therapeutix's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
